Latest Strategic Funding News

Vanadium Resources Limited (VR8) reports ongoing strategic equity and offtake discussions with tier-1 partners for its Steelpoortdrift Vanadium Project, alongside cost reduction measures and progress on environmental approvals.

Burley Minerals Ltd reports significant progress in its Western Australian iron ore projects, highlighted by promising high-grade assay results and imminent drilling campaigns, while actively exploring strategic funding options amid recent sector M&A activity.

Clean TeQ Water Limited reports a landmark $11 million contract for its PHOSPHIX® phosphate removal plant in Ireland, alongside successful project deliveries and lithium recovery breakthroughs, setting the stage for improved financial performance in 2025.

Xanadu Mines has delivered a landmark Pre-Feasibility Study and Maiden Ore Reserve for its Kharmagtai Copper-Gold Project, confirming its status as a world-class asset. The company also secured $7.5 million in funding and transitioned project operatorship to Zijin Mining, setting the stage for a Bankable Feasibility Study.

MetalsTech Limited has secured a $5 million working capital facility and engaged Mining One to complete a Pre-Feasibility Study for its Sturec Gold Mine in Slovakia, following an updated Scoping Study that reveals strong project economics.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Pilot Energy Limited has announced a substantial 58% increase in the carbon storage capacity of its Cliff Head project, alongside securing $6.3 million in capital and advancing a joint venture for Direct Air Capture technology.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.

Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.

Papyrus Australia Ltd reported a $284,000 net cash outflow for the December 2024 quarter, reflecting abnormal expenses but maintaining a solid funding runway through existing facilities and strategic initiatives.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Globe Metals & Mining has reached a pivotal funding milestone with a US$10 million convertible loan agreement, propelling the Kanyika Niobium Project closer to development. The updated feasibility study remains on track for completion by March/April 2025, underpinning the project's execution phase.